• 1. Programmed synthesis of triarylnitroimidazoles via sequential cross-coupling reactions
  Gaurav Raina,Prakash Kannaboina,Nagaraju Mupparapu,Sushil Raina,Qazi Naveed Ahmed,Parthasarathi Das Org. Biomol. Chem. 2019 17 2134
• 2. A fruitful century for the scalable synthesis and reactions of biphenyl derivatives: applications and biological aspects
  Hajar A. Ali,Mohamed A. Ismail,Abd El-Aziz S. Fouda,Eslam A. Ghaith RSC Adv. 2023 13 18262
• 3. Palladium catalyzed C–C and C–N bond forming reactions: an update on the synthesis of pharmaceuticals from 2015–2020
  Jayachandra Rayadurgam,Sravani Sana,M. Sasikumar,Qiong Gu Org. Chem. Front. 2021 8 384

• Solvents and Organic Chemicals Organic Compounds Benzenoids Phenol ethers Phenol ethers
• Solvents and Organic Chemicals Organic Compounds Benzenoids Phenol ethers
• Other Chemical Reagents Derivatization Reagents
• Solvents and Organic Chemicals Organic Compounds Acids/Esters

Recent Advances in the Application of [4-(trifluoromethoxy)phenyl]boronic acid (CAS: 139301-27-2) in Chemical Biology and Pharmaceutical Research

The compound [4-(trifluoromethoxy)phenyl]boronic acid (CAS: 139301-27-2) has garnered significant attention in recent years due to its versatile applications in chemical biology and pharmaceutical research. This boronic acid derivative is particularly valued for its ability to form stable covalent interactions with diols and other nucleophiles, making it a crucial building block in the development of sensors, prodrugs, and targeted therapeutics. Recent studies have explored its potential in areas such as cancer therapy, enzyme inhibition, and diagnostic tool development, highlighting its broad utility in biomedical sciences.

One of the most promising applications of [4-(trifluoromethoxy)phenyl]boronic acid is in the field of targeted drug delivery. Researchers have successfully incorporated this compound into prodrug systems that are activated by specific biomarkers, such as reactive oxygen species (ROS) or elevated glucose levels in tumor microenvironments. A 2023 study published in the Journal of Medicinal Chemistry demonstrated that conjugates of this boronic acid with anticancer agents showed enhanced selectivity for cancer cells, reducing off-target effects and improving therapeutic indices. The trifluoromethoxy group's unique electronic properties were found to significantly influence the compound's binding affinity and metabolic stability.

In the realm of chemical biology, [4-(trifluoromethoxy)phenyl]boronic acid has emerged as a valuable tool for protein labeling and modification. Its ability to form reversible covalent bonds with serine residues in proteins has enabled the development of novel proteomic techniques. Recent work published in ACS Chemical Biology (2024) utilized this compound as a key component in activity-based protein profiling (ABPP) probes, allowing for the selective labeling of active enzyme sites in complex biological samples. This approach has provided new insights into enzyme function and regulation in disease states.

The compound's utility extends to materials science applications as well. A 2024 study in Advanced Materials reported the incorporation of [4-(trifluoromethoxy)phenyl]boronic acid into polymeric sensors for glucose detection. The resulting materials demonstrated improved sensitivity and selectivity compared to conventional sensors, with potential applications in continuous glucose monitoring systems for diabetes management. The trifluoromethoxy moiety was found to enhance the material's stability in biological fluids while maintaining excellent recognition properties.

From a synthetic chemistry perspective, recent advances have focused on developing more efficient routes to [4-(trifluoromethoxy)phenyl]boronic acid and its derivatives. A 2023 publication in Organic Process Research & Development described a scalable, transition-metal-free synthesis method that significantly improves yield and reduces production costs. This development is particularly important as it addresses previous limitations in the commercial availability of high-purity material for research and potential clinical applications.

Looking forward, the unique properties of [4-(trifluoromethoxy)phenyl]boronic acid (CAS: 139301-27-2) continue to inspire innovative applications across multiple disciplines. Current research directions include the development of boronic acid-based covalent drugs, advanced diagnostic tools, and smart biomaterials. As our understanding of boronic acid chemistry deepens, this compound is poised to play an increasingly important role in bridging chemical synthesis with biological applications, offering new solutions to longstanding challenges in medicine and biotechnology.

• 870822-76-7(Boronic acid,B-[8-(trifluoromethoxy)-2-naphthalenyl]-)
• 355836-10-1([2-methoxy-4-(trifluoromethoxy)phenyl]boronic acid)
• 1079402-25-7(5-Methoxy-2-(trifluoromethoxy)phenylboronic Acid)
• 179113-90-7(m-(Trifluoromethoxy)phenylboronic Acid)
• 290832-43-8([2-methoxy-5-(trifluoromethoxy)phenyl]boronic acid)
• 1256345-88-6((3-Methoxy-5-(trifluoromethoxy)phenyl)boronic acid)
• 957120-22-8(3-Hydroxy-5-(trifluoromethoxy)phenylboronic acid)
• 175676-65-0(o-(Trifluoromethoxy)phenylboronic Acid)
• 866607-09-2([3-(difluoromethoxy)phenyl]boronic acid)
• 688810-12-0([4-(difluoromethoxy)phenyl]boronic acid)